Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender

We investigated risk association of oral cancers (tongue and buccal mucosa cancers) with FAS (−1377G > A and FAS −670 A > G) and FASL (−844 T > C) SNPs, in males and females. A case–control study of 535 oral cancer and 525 control subjects was performed. SNPs were detected in the genomic DN...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tumor biology 2015-09, Vol.36 (10), p.7817-7830
Hauptverfasser: Daripally, Sarika, Nallapalle, Sateesh Reddy, Katta, Saritha, Prasad, Vidudala V. T. S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7830
container_issue 10
container_start_page 7817
container_title Tumor biology
container_volume 36
creator Daripally, Sarika
Nallapalle, Sateesh Reddy
Katta, Saritha
Prasad, Vidudala V. T. S.
description We investigated risk association of oral cancers (tongue and buccal mucosa cancers) with FAS (−1377G > A and FAS −670 A > G) and FASL (−844 T > C) SNPs, in males and females. A case–control study of 535 oral cancer and 525 control subjects was performed. SNPs were detected in the genomic DNA isolated from peripheral blood using PCR-RFLP. We report FASL −844 T > C SNPs increased risk for buccal mucosa cancer in females but not in males. On the other hand, FAS genotypes did not alter the risk of the cancers in both females and males. However, co-occurrence of FAS −1377 GA and −670 GG, FAS −1377 AA and −670 GG genotypes, and combined genotypes of FAS and FASL ( FAS −1377 AA +  FAS −670 GG +  FASL −844 CC) alter male susceptibility towards tongue cancer. In females, combined genotypes of FAS (−1377GA and −670 AA) were found to be a risk factor of buccal mucosa cancer (OR = 3.27, CI = 1.28–8.36; P  ≤ 0.01). FASL variants (GA and AA) increased tongue cancer risk in females who were tobacco users compared to non-tobacco users. In conclusion, SNPs of the FAS and FASL might alter risk of tongue and buccal mucosa cancers differentially, in a gender-dependent manner.
doi_str_mv 10.1007/s13277-015-3516-x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1722927389</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3836286181</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-57627646c36fb40ea5a915bf10a87a77edcc351c872439ca99956fb25f2ca3a03</originalsourceid><addsrcrecordid>eNp1kUtLAzEUhYMovn-AGwm4cTOadyZLqU8oKlTXIZNm2pF51CSj9t8bO1VEcJUL-e6599wDwBFGZxgheR4wJVJmCPOMciyyjw2wixmhGaI52kw1wihjJKc7YC-EF5RApcQ22CFcMYaF3AXFpA_WLWJVVHUVlzB2sPOmhta01vkA36s4h6NLxaFpp6tiDBe-a7roPJzcPwbYmCV8M345oHHuYKiiW-Ez106dPwBbpamDO1y_--D5-uppdJuNH27uRhfjzDJGYsalIFIwYakoC4ac4UZhXpQYmVwaKd3U2uTS5pIwqqxRSvFEEl4Sa6hBdB-cDrppv9fehaibKnmra9O6rg8aS0IUkTRXCT35g750vW_TdisKqVwxkSg8UNZ3IXhX6oWvmmRVY6S_AtBDADrdVX8FoD9Sz_FauS8aN_3p-L54AsgAhPTVzpz_Nfpf1U8CH48J</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1722098946</pqid></control><display><type>article</type><title>Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Daripally, Sarika ; Nallapalle, Sateesh Reddy ; Katta, Saritha ; Prasad, Vidudala V. T. S.</creator><creatorcontrib>Daripally, Sarika ; Nallapalle, Sateesh Reddy ; Katta, Saritha ; Prasad, Vidudala V. T. S.</creatorcontrib><description>We investigated risk association of oral cancers (tongue and buccal mucosa cancers) with FAS (−1377G &gt; A and FAS −670 A &gt; G) and FASL (−844 T &gt; C) SNPs, in males and females. A case–control study of 535 oral cancer and 525 control subjects was performed. SNPs were detected in the genomic DNA isolated from peripheral blood using PCR-RFLP. We report FASL −844 T &gt; C SNPs increased risk for buccal mucosa cancer in females but not in males. On the other hand, FAS genotypes did not alter the risk of the cancers in both females and males. However, co-occurrence of FAS −1377 GA and −670 GG, FAS −1377 AA and −670 GG genotypes, and combined genotypes of FAS and FASL ( FAS −1377 AA +  FAS −670 GG +  FASL −844 CC) alter male susceptibility towards tongue cancer. In females, combined genotypes of FAS (−1377GA and −670 AA) were found to be a risk factor of buccal mucosa cancer (OR = 3.27, CI = 1.28–8.36; P  ≤ 0.01). FASL variants (GA and AA) increased tongue cancer risk in females who were tobacco users compared to non-tobacco users. In conclusion, SNPs of the FAS and FASL might alter risk of tongue and buccal mucosa cancers differentially, in a gender-dependent manner.</description><identifier>ISSN: 1010-4283</identifier><identifier>EISSN: 1423-0380</identifier><identifier>DOI: 10.1007/s13277-015-3516-x</identifier><identifier>PMID: 25944167</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Carcinoma, Squamous Cell - genetics ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - secondary ; Carcinoma, Verrucous - genetics ; Carcinoma, Verrucous - mortality ; Carcinoma, Verrucous - secondary ; Case-Control Studies ; Fas Ligand Protein - genetics ; fas Receptor - genetics ; Female ; Follow-Up Studies ; Gender Identity ; Genetic Predisposition to Disease ; Genotype ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Mouth Mucosa ; Mouth Neoplasms - genetics ; Mouth Neoplasms - mortality ; Mouth Neoplasms - pathology ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local - genetics ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging ; Oral cancer ; Polymerase Chain Reaction ; Polymorphism ; Polymorphism, Restriction Fragment Length ; Polymorphism, Single Nucleotide - genetics ; Prognosis ; Promoter Regions, Genetic - genetics ; Research Article ; Risk Factors ; Survival Rate ; Tongue ; Young Adult</subject><ispartof>Tumor biology, 2015-09, Vol.36 (10), p.7817-7830</ispartof><rights>International Society of Oncology and BioMarkers (ISOBM) 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-57627646c36fb40ea5a915bf10a87a77edcc351c872439ca99956fb25f2ca3a03</citedby><cites>FETCH-LOGICAL-c442t-57627646c36fb40ea5a915bf10a87a77edcc351c872439ca99956fb25f2ca3a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13277-015-3516-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s13277-015-3516-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27904,27905,41468,42537,51299</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25944167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Daripally, Sarika</creatorcontrib><creatorcontrib>Nallapalle, Sateesh Reddy</creatorcontrib><creatorcontrib>Katta, Saritha</creatorcontrib><creatorcontrib>Prasad, Vidudala V. T. S.</creatorcontrib><title>Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender</title><title>Tumor biology</title><addtitle>Tumor Biol</addtitle><addtitle>Tumour Biol</addtitle><description>We investigated risk association of oral cancers (tongue and buccal mucosa cancers) with FAS (−1377G &gt; A and FAS −670 A &gt; G) and FASL (−844 T &gt; C) SNPs, in males and females. A case–control study of 535 oral cancer and 525 control subjects was performed. SNPs were detected in the genomic DNA isolated from peripheral blood using PCR-RFLP. We report FASL −844 T &gt; C SNPs increased risk for buccal mucosa cancer in females but not in males. On the other hand, FAS genotypes did not alter the risk of the cancers in both females and males. However, co-occurrence of FAS −1377 GA and −670 GG, FAS −1377 AA and −670 GG genotypes, and combined genotypes of FAS and FASL ( FAS −1377 AA +  FAS −670 GG +  FASL −844 CC) alter male susceptibility towards tongue cancer. In females, combined genotypes of FAS (−1377GA and −670 AA) were found to be a risk factor of buccal mucosa cancer (OR = 3.27, CI = 1.28–8.36; P  ≤ 0.01). FASL variants (GA and AA) increased tongue cancer risk in females who were tobacco users compared to non-tobacco users. In conclusion, SNPs of the FAS and FASL might alter risk of tongue and buccal mucosa cancers differentially, in a gender-dependent manner.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Carcinoma, Squamous Cell - genetics</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - secondary</subject><subject>Carcinoma, Verrucous - genetics</subject><subject>Carcinoma, Verrucous - mortality</subject><subject>Carcinoma, Verrucous - secondary</subject><subject>Case-Control Studies</subject><subject>Fas Ligand Protein - genetics</subject><subject>fas Receptor - genetics</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gender Identity</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>Humans</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mouth Mucosa</subject><subject>Mouth Neoplasms - genetics</subject><subject>Mouth Neoplasms - mortality</subject><subject>Mouth Neoplasms - pathology</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local - genetics</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging</subject><subject>Oral cancer</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>Prognosis</subject><subject>Promoter Regions, Genetic - genetics</subject><subject>Research Article</subject><subject>Risk Factors</subject><subject>Survival Rate</subject><subject>Tongue</subject><subject>Young Adult</subject><issn>1010-4283</issn><issn>1423-0380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kUtLAzEUhYMovn-AGwm4cTOadyZLqU8oKlTXIZNm2pF51CSj9t8bO1VEcJUL-e6599wDwBFGZxgheR4wJVJmCPOMciyyjw2wixmhGaI52kw1wihjJKc7YC-EF5RApcQ22CFcMYaF3AXFpA_WLWJVVHUVlzB2sPOmhta01vkA36s4h6NLxaFpp6tiDBe-a7roPJzcPwbYmCV8M345oHHuYKiiW-Ez106dPwBbpamDO1y_--D5-uppdJuNH27uRhfjzDJGYsalIFIwYakoC4ac4UZhXpQYmVwaKd3U2uTS5pIwqqxRSvFEEl4Sa6hBdB-cDrppv9fehaibKnmra9O6rg8aS0IUkTRXCT35g750vW_TdisKqVwxkSg8UNZ3IXhX6oWvmmRVY6S_AtBDADrdVX8FoD9Sz_FauS8aN_3p-L54AsgAhPTVzpz_Nfpf1U8CH48J</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Daripally, Sarika</creator><creator>Nallapalle, Sateesh Reddy</creator><creator>Katta, Saritha</creator><creator>Prasad, Vidudala V. T. S.</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150901</creationdate><title>Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender</title><author>Daripally, Sarika ; Nallapalle, Sateesh Reddy ; Katta, Saritha ; Prasad, Vidudala V. T. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-57627646c36fb40ea5a915bf10a87a77edcc351c872439ca99956fb25f2ca3a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Carcinoma, Squamous Cell - genetics</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - secondary</topic><topic>Carcinoma, Verrucous - genetics</topic><topic>Carcinoma, Verrucous - mortality</topic><topic>Carcinoma, Verrucous - secondary</topic><topic>Case-Control Studies</topic><topic>Fas Ligand Protein - genetics</topic><topic>fas Receptor - genetics</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gender Identity</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>Humans</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mouth Mucosa</topic><topic>Mouth Neoplasms - genetics</topic><topic>Mouth Neoplasms - mortality</topic><topic>Mouth Neoplasms - pathology</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local - genetics</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging</topic><topic>Oral cancer</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>Prognosis</topic><topic>Promoter Regions, Genetic - genetics</topic><topic>Research Article</topic><topic>Risk Factors</topic><topic>Survival Rate</topic><topic>Tongue</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Daripally, Sarika</creatorcontrib><creatorcontrib>Nallapalle, Sateesh Reddy</creatorcontrib><creatorcontrib>Katta, Saritha</creatorcontrib><creatorcontrib>Prasad, Vidudala V. T. S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Tumor biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daripally, Sarika</au><au>Nallapalle, Sateesh Reddy</au><au>Katta, Saritha</au><au>Prasad, Vidudala V. T. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender</atitle><jtitle>Tumor biology</jtitle><stitle>Tumor Biol</stitle><addtitle>Tumour Biol</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>36</volume><issue>10</issue><spage>7817</spage><epage>7830</epage><pages>7817-7830</pages><issn>1010-4283</issn><eissn>1423-0380</eissn><abstract>We investigated risk association of oral cancers (tongue and buccal mucosa cancers) with FAS (−1377G &gt; A and FAS −670 A &gt; G) and FASL (−844 T &gt; C) SNPs, in males and females. A case–control study of 535 oral cancer and 525 control subjects was performed. SNPs were detected in the genomic DNA isolated from peripheral blood using PCR-RFLP. We report FASL −844 T &gt; C SNPs increased risk for buccal mucosa cancer in females but not in males. On the other hand, FAS genotypes did not alter the risk of the cancers in both females and males. However, co-occurrence of FAS −1377 GA and −670 GG, FAS −1377 AA and −670 GG genotypes, and combined genotypes of FAS and FASL ( FAS −1377 AA +  FAS −670 GG +  FASL −844 CC) alter male susceptibility towards tongue cancer. In females, combined genotypes of FAS (−1377GA and −670 AA) were found to be a risk factor of buccal mucosa cancer (OR = 3.27, CI = 1.28–8.36; P  ≤ 0.01). FASL variants (GA and AA) increased tongue cancer risk in females who were tobacco users compared to non-tobacco users. In conclusion, SNPs of the FAS and FASL might alter risk of tongue and buccal mucosa cancers differentially, in a gender-dependent manner.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>25944167</pmid><doi>10.1007/s13277-015-3516-x</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1010-4283
ispartof Tumor biology, 2015-09, Vol.36 (10), p.7817-7830
issn 1010-4283
1423-0380
language eng
recordid cdi_proquest_miscellaneous_1722927389
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Biomedical and Life Sciences
Biomedicine
Cancer Research
Carcinoma, Squamous Cell - genetics
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - secondary
Carcinoma, Verrucous - genetics
Carcinoma, Verrucous - mortality
Carcinoma, Verrucous - secondary
Case-Control Studies
Fas Ligand Protein - genetics
fas Receptor - genetics
Female
Follow-Up Studies
Gender Identity
Genetic Predisposition to Disease
Genotype
Humans
Lymphatic Metastasis
Male
Middle Aged
Mouth Mucosa
Mouth Neoplasms - genetics
Mouth Neoplasms - mortality
Mouth Neoplasms - pathology
Neoplasm Invasiveness
Neoplasm Recurrence, Local - genetics
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Oral cancer
Polymerase Chain Reaction
Polymorphism
Polymorphism, Restriction Fragment Length
Polymorphism, Single Nucleotide - genetics
Prognosis
Promoter Regions, Genetic - genetics
Research Article
Risk Factors
Survival Rate
Tongue
Young Adult
title Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T09%3A58%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Susceptibility%20to%20oral%20cancers%20with%20CD95%20and%20CD95L%20promoter%20SNPs%20may%20vary%20with%20the%20site%20and%20gender&rft.jtitle=Tumor%20biology&rft.au=Daripally,%20Sarika&rft.date=2015-09-01&rft.volume=36&rft.issue=10&rft.spage=7817&rft.epage=7830&rft.pages=7817-7830&rft.issn=1010-4283&rft.eissn=1423-0380&rft_id=info:doi/10.1007/s13277-015-3516-x&rft_dat=%3Cproquest_cross%3E3836286181%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1722098946&rft_id=info:pmid/25944167&rfr_iscdi=true